Jeffrey M. Trent Lecturship in Cancer Research Series

Event Details

Jeffrey M. Trent, Ph.D., F.A.C.M.G, was the National Human Genome Research Institute's (NHGRI) founding scientific director, serving in this role for more than nine years. His leadership and vision were instrumental in establishing NHGRI's Division of Intramural Research as one of the premier research programs in the world devoted to genetics and genomics.In recognition of his significant contributions to the research environment at the National Institutes of Health (NIH), NHGRI established the annual Jeffrey M. Trent Lecture in Cancer Research in 2003. This lecture is given by a prominent cancer researcher who brings the kind of energy, creativity and enthusiasm to cancer research that Dr. Trent has exemplified throughout his career. 

Lipsett Amphitheater, Building 10 (Clinical Center)

National Institutes of Health (NIH) Bethesda Campus

2019

The National Human Genome Research Institute's Division of Intramural Research will present the 15th Jeffrey M. Trent Lecture in Cancer Research on June 14, 2019, 2:00 - 3:00 p.m., at the Lipsett Amphitheater, Building 10 (Clinical Center), on the National Institutes of Health (NIH) Bethesda campus. Jay Shendure, M.D., Ph.D., Investigator of the Howard Hughes Medical Institute (HHMI) and Professor of Genome Sciences at the University of Washington will deliver the lecture New Frontiers in Genomics.

Jay Shendure

 

2018

The National Human Genome Research Institute's Division of Intramural Research presented the 14th Jeffrey M. Trent Lecture in Cancer Research on March 15, 2018, 12:00 - 1:00 p.m., at the Lipsett Amphitheater, Building 10 (Clinical Center), on the National Institutes of Health (NIH) Bethesda campus. Joan Brugge, Ph.D., co-director, Ludwig Center at Harvard Medical School, will deliver the lecture Role of the TRPA1 Ca2+-permeable Channel in Oxidative Stress Defenses in Cancer.

2015

The National Human Genome Research Institute's Division of Intramural Research presented the 11th Jeffrey M. Trent Lecture in Cancer Research at 1 p.m. on Wednesday, February 11, 2015, at the Masur Auditorium, Building 10 (Clinical Center), on the National Institutes of Health (NIH) Bethesda campus. Stephen J. Chanock, M.D., director of the National Cancer Institute's (NCI) Division of Cancer Epidemiology and Genetics, part of NIH, delivered the lecture on the genetic susceptibility to cancer.

2017

The National Human Genome Research Institute's Division of Intramural Research will present the 13th Jeffrey M. Trent Lecture in Cancer Research on Wednesday, Sept. 6, 2017, at the Lipsett Amphitheater, Building 10 (Clinical Center), on the National Institutes of Health (NIH) Bethesda campus. Katherine A. Janeway, M.D., MMSc, the clinical director of the Solid Tumor Program for the Dana Farber-Boston/Children's Cancer and Blood Disorders Center, will deliver the lecture Bringing Genomics to the Pediatric Oncology Clinic: Diagnosis, Treatment Selection and Rational Clinical Trial Design.

2016

The National Human Genome Research Institute's Division of Intramural Research will present the 12th Jeffrey M. Trent Lecture in Cancer Research at 2 p.m. on Wednesday, May 4, 2016, at the Lipsett Amphitheater, Building 10 (Clinical Center), on the National Institutes of Health (NIH) Bethesda campus. John D. Carpten, Ph.D., chair of the Department of Translational Genomics and director of the Institute of Translational Genomics, Keck School of Medicine, University of Southern California, will deliver the lecture.

2009

The seventh annual Jeffrey M. Trent Lecture in Cancer Research - Telomerase and the Consequences of Telomere Dysfunction - will be held on Tuesday, Jan. 19, 2010 from 1 to 2 p.m. This year's lecture will be given by Carol Greider, Ph.D., Daniel Nathans Professor and Director, Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, and 2009 Nobel Laureate in Physiology or Medicine. The lecture will take place in the Masur Auditorium (with live feed overflow in Lipsett Amphitheatre), National Institutes of Health (NIH) Clinical Center, Building 10 on the NIH campus.

2007

The fifth annual Jeffrey M.Trent Lecture in Cancer Research was held on Tuesday, October 16, 2007. Presented by Eric S. Lander, Ph.D., founding director of the Broad Institute of M.I.T. and Harvard, the lecture was presented at Masur Auditorium, National Institutes of Health (NIH) Clinical Center, Building 10 on the NIH campus.


About Jeffrey Trent

Jeffrey Trent

Jeffrey M. Trent, Ph.D., F.A.C.M.G, was the National Human Genome Research Institute's (NHGRI) founding scientific director, serving in this role for more than nine years. His leadership and vision were instrumental in establishing NHGRI's Division of Intramural Research as one of the premier research programs in the world devoted to genetics and genomics. In recognition of his significant contributions to the research environment at the National Institutes of Health (NIH), NHGRI established the annual Jeffrey M. Trent Lecture in Cancer Research in 2003. This lecture is given by a prominent cancer researcher who brings the kind of energy, creativity and enthusiasm to cancer research that Dr. Trent has exemplified throughout his career. 

Dr. Trent received his undergraduate degree from Indiana University, Bloomington, and his M.S. and Ph.D. degrees in genetics from the University of Arizona, Tucson. Prior to joining NHGRI, he was the Emanuel N. Maisel Professor of Oncology and Professor of Radiation Oncology and Human Genetics at the University of Michigan, Ann Arbor. He also served as director of the Division of Cancer Biology, and director of basic sciences at the University of Michigan Comprehensive Cancer Center. In 1993, Dr. Trent came to NIH with Dr. Francis Collins to establish and direct its newly formed Division of Intramural Research. Following his departure from NHGRI, Dr. Trent became the founding president and research director of the Translational Genomics Research Institute (TGen) in Phoenix. 

Dr. Trent's research has provided important insights into the genetic basis of cancer. He is the author of more than 350 manuscripts in the scientific literature, numerous book chapters, invited reviews, and has given hundreds of invited lectures. He has received numerous honors and awards, and has sat on the editorial boards of a dozen scientific publications. He specializes in developing and integrating novel "omic" technologies, in support of clinical decision support in oncology patients. 

Dr. Trent continues to lead studies of the genetic basis of various complex diseases in humans, as well as leading TGen's canine hereditary cancer program.

Contact

Nora Miralieva
Nora Miralieva, M.B.A.
  • Special Assistant for Operations
  • Office of the Scientific Director